Metabolic Dysfunction in New‐Onset Idiopathic Intracranial Hypertension: Identification of Novel Biomarkers
Annals of Neurology · 2024-09 · 96 (3) · 595-607
DOI: 10.1002/ana.27010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 22.06.2024. Verfasst von Johanne Juhl Korsbæk und 10 weiteren Autor:innen. Beteiligte Einrichtung: Danish Headache Center, Department of Neurology, Rigshospitalet, Glostrup, Denmark. Hauptthemen laut MEDLINE: Biomarkers, Pseudotumor Cerebri. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Odense Universitetshospital, Lundbeck Foundation, Odense University Hospital and Rigshospitalet.
Abstract (Originalsprache)
Objective
Idiopathic intracranial hypertension (IIH) is a neurometabolic disease with an increasing incidence. The pathophysiology is unknown, but improvement of diagnosis and management requires discovery of novel biomarkers. Our objective was to identify such candidate biomarkers in IIH, and secondarily, test for associations between identified metabolites and disease severity.
Methods
This is a prospective case–control study with collection of cerebrospinal fluid (CSF), serum, and clinical data from new‐onset, treatment‐naïve patients with IIH (n = 60). Patients were included consecutively from 2 tertiary headache centers in Denmark, and age, sex, and body mass index (BMI) ‐matched healthy controls (n = 35) were recruited. Clinical data were retrieved at ocular remission (n = 55). Samples were analyzed using non‐targeted mass spectrometry.
Results
Serum sphingosine 1‐phosphate (S1P), adenosine, and glutamate were 0.46‐fold (q < 0.0001), 0.25‐fold (q = 0.0048), and 0.44‐fold (q < 0.0001) lower, respectively, in IIH. CSF stearoyl‐lysophosphatidylcholine (LysoPC‐18) and 2‐palmitoyl‐lysophosphatidylcholine (LysoPC‐16) were 0.42 (q = 0.0025) and 0.37 (q < 0.001) ‐fold lower. LysoPC‐18 was higher in patients with moderate–severe versus mild papilledema ( p = 0.022). LysoPC‐18 correlated positively with retinal nerve fiber layer thickness ( p = 0.0012, r = 0.42) and inversely with mean deviation on automated perimetry ( p = 0.01, r = −0.35). Higher baseline serum S1P ( p = 0.018) and lower CSF LysoPC‐16 ( p = 0.003) were associated with optic nerve atrophy at ocular remission. Pathway analysis suggests dysregulated lipid metabolism and redox disturbances in new‐onset IIH.
Interpretation
We identify perturbed metabolism in new‐onset IIH. S1P and LysoPC‐16 demonstrate potential prognostic value due to association with subsequent optic nerve atrophy. This association between specific, differential metabolites and outcome provides substantial evidence for novel biomarkers of clinical significance that should be the focus of further targeted studies. ANN NEUROL 2024;96:595–607
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Danish Headache Center, Department of Neurology, Rigshospitalet, Glostrup, Denmark.
- Translational Research Centre, Rigshospitalet, Glostrup, Denmark.
- Headache Clinic, Department of Neurology, Odense University Hospital, Odense, Denmark.
- Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- OPEN, Odense Patient data Explorative Network, Odense University Hospital, Odense, Denmark.
- Department of Ophthalmology, Rigshospitalet, Glostrup, Denmark.
ORCID-Profile: Dagmar Beier, Thomas Folkmann Hansen, Lisette J A Kogelman, Connar Stanley James Westgate
Förderung
- Odense Universitetshospital
- Lundbeck Foundation
- Odense University Hospital and Rigshospitalet
- Candys Foundation
Zitieren
APA
Korsbæk, J. J., Jensen, R. H., Beier, D., Wibroe, E. A., Hagen, S. M., Molander, L. D., Gillum, M. P., Svart, K., Hansen, T. F., Kogelman, L. J. A., & Westgate, C. S. J. (2024). Metabolic Dysfunction in New‐Onset Idiopathic Intracranial Hypertension: Identification of Novel Biomarkers. Annals of Neurology, 96(3), 595-607. https://doi.org/10.1002/ana.27010
Vancouver
Korsbæk JJ, Jensen RH, Beier D, Wibroe EA, Hagen SM, Molander LD, et al. Metabolic Dysfunction in New‐Onset Idiopathic Intracranial Hypertension: Identification of Novel Biomarkers. Annals of Neurology. 2024;96(3):595-607. doi:10.1002/ana.27010
BibTeX
@article{Korsbk2024,
author = {Korsbæk, Johanne Juhl and Jensen, Rigmor Højland and Beier, Dagmar and Wibroe, Elisabeth Arnberg and Hagen, Snorre Malm and Molander, Laleh Dehghani and Gillum, Matthew Paul and Svart, Katrine and Hansen, Thomas Folkmann and Kogelman, Lisette J A and Westgate, Connar Stanley James},
title = {Metabolic Dysfunction in New‐Onset Idiopathic Intracranial Hypertension: Identification of Novel Biomarkers},
journal = {Annals of Neurology},
year = {2024},
volume = {96},
number = {3},
pages = {595--607},
doi = {10.1002/ana.27010}
}
EUVIMED